icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
ACH-2684: HCV NS3 PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST MULTIPLE GENOTYPES AND KNOWN RESISTANT VARIANTS
 
 
  Reported by Jules Levin
Presented at AASLD The Liver Meeting Boston, MA, USA, October 29 - Novermber 2, 2010
 
Mingjun Huang, Steven Podos, Dharaben Patel, Guangwei Yang, Joanne Fabrycki, Yongsen Zhao, Christopher Marlor, Preeti Kapoor, Xiangzhu Wang, Akihiro Hashimoto, Venkat Gadhachanda, Godwin Pais, Dawei Chen, Atul Agarwal, Milind Deshpande, Kathe Stauber, and Avinash Phadke

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif